Amneal Pharmaceuticals announces its nizatidine oral solution 15 mg/mL (75 mg/5 mL), a generic equivalent of Axid, available for reorder. Meeting all FDA requirements and specification limits related to NDMA, the solution is used for the short-term treatment and maintenance therapy of ulcers and the treatment of esophagitis and heartburn due to gastroesophageal reflux disease (GERD). The solution is available as a peppermint-flavored liquid in 480 mL bottles.

Amneal Pharmaceuticals